A Phase 1 Clinical Study of Intravenous Administration of PV701, an Oncolytic Virus, Using Two-Step DesensitizationScott A. Laurie, Robert M. Lorence, John C. Bell et al.|Clinical Cancer Research|2006Cited by 128
A phase II trial of afatinib (BIBW 2992) in patients (pts) with advanced non-small cell lung cancer previously treated with erlotinib (E) or gefitinib (G).Nobuyuki Yamamoto, Maryam Shahidi, A. Inoue et al.|Journal of Clinical Oncology|2011Cited by 25
Phase II study of afatinib plus pembrolizumab in patients with squamous cell carcinoma of the lung following progression during or after first-line chemotherapy (LUX-Lung-IO)Benjamin Levy, Jonathan W. Riess, Fabrice Barlési et al.|Lung Cancer|2022Cited by 7